Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Takahide Teramoto"'
Autor:
Hiroshi Odajima, Motohiro Ebisawa, Toshikazu Nagakura, Takao Fujisawa, Akira Akasawa, Komei Ito, Satoru Doi, Koichi Yamaguchi, Toshio Katsunuma, Kazuyuki Kurihara, Takahide Teramoto, Kazuko Sugai, Mitsuhiko Nambu, Akira Hoshioka, Shigemi Yoshihara, Norio Sato, Noriko Seko, Sankei Nishima
Publikováno v:
Allergology International, Vol 66, Iss 1, Pp 106-115 (2017)
Background: Omalizumab is effective and well-tolerated in children with moderate to severe allergic asthma. However, the effects of long-term treatment with omalizumab in this population haven't been well investigated. The objective of this study is
Externí odkaz:
https://doaj.org/article/cde48f6031454391aa0c0d1dc510ac21
Autor:
Takahide Teramoto, Eiko Matsui, Toshiyuki Fukao, Kazuaki Sakai, Hiroshi Yonezawa, Zenichiro Kato, Hidenori Ohnishi, Hideo Kaneko, Naomi Kondo, Junichi Azuma, Sankei Nishima
Publikováno v:
Allergology International, Vol 61, Iss 4, Pp 619-624 (2012)
Background: Ciclesonide (CIC) is a highly safe, inhaled corticosteroid (ICS) that is converted into a pharmacologically active metabolite (des-isobutyryl-ciclesonide); this metabolite, in turn, exerts a local antiinflammatory effect on lung tissue. T
Externí odkaz:
https://doaj.org/article/f6ced461e99b477799615ec840497fd4
Autor:
Takahide Teramoto, Toshiyuki Fukao, Yoshiko Tomita, Yoshiaki Terauchi, Kaori Hosoi, Eiko Matsui, Minako Aoki, Naomi Kondo, Haruki Mikawa
Publikováno v:
Allergology International, Vol 55, Iss 3, Pp 317-320 (2006)
Background: Hydrofluoroalkane-134a (HFA) has been shown to be a safe replacement for chlorofluorocarbons (CFCs) as a pharmaceutical propellant, with the advantage that it has no ozone-depleting potential. This is the first report of the pharmacokinet
Externí odkaz:
https://doaj.org/article/e15d278d4a15434293981e7cb9486f1a
Autor:
Toshiyuki Fukao, Osamu Fukutomi, Kouichiro Hirayama, Takahide Teramoto, Hideo Kaneko, Masashi Kondo, Eiko Matsui, Naomi Kondo
Publikováno v:
Allergology International, Vol 54, Iss 4, Pp 521-526 (2005)
Background: It is still unclear how early exposure to pets is related to the risk of developing atopy-related diseases in children. There are few reports on this pet-allergy relationship in Japan although much controversial data have been reported in
Externí odkaz:
https://doaj.org/article/77322e960be5499b9de3e9466e9526ab
Autor:
Naomi Kondo, Eiko Matsui, Hideo Kaneko, Zenichiro Kato, Toshiyuki Fukao, Takahide Teramoto, Hiroaki Shikano, Minako Aoki, Hidenori Onishi, Koji Tatebayashi, Kentaro Omoya, Masashi Kondo, Eiji Matsukuma, Kimiko Kasahara, Naoko Morimoto
Publikováno v:
Allergology International, Vol 53, Iss 2, Pp 77-85 (2004)
Atopic disorders, such as asthma, eczema and rhinitis, develop due to the interactions between genetic and environmental factors. Atopy is characterized by enhanced IgE responses to environmental antigens. The production of IgE is upregulated by Th2
Externí odkaz:
https://doaj.org/article/e0b455618a5145f6b6f244332fe5dd49
Autor:
Kaori Yoshikawa, Eiko Matsui, Ryosuke Inoue, Hideo Kaneko, Takahide Teramoto, Minako Aoki, Kimiko Kasahara, Shinji Shinoda, Osamu Fukutomi, Naomi Kondo
Publikováno v:
Allergology International, Vol 53, Iss 2, Pp 127-134 (2004)
Background: Cysteinyl leukotrienes (CysLTs) and thromboxane (TX) A2 have been implicated in the pathogenesis of bronchial asthma. Urinary leukotriene E4 (LTE4) and 11-dehydro-TXB2 (11 DTXB2) levels are often used to assess the production of CysLTs an
Externí odkaz:
https://doaj.org/article/816618ad21534689b5b98eb546535734
Autor:
Ryosuke Inoue, Takahide Teramoto, Susumu Nakade, Hiroyuki Okamoto, Eiji Yukawa, Shun Higuchi, Naomi Kondo, Haruki Mikawa
Publikováno v:
Allergology International, Vol 52, Iss 4, Pp 213-218 (2003)
Background: This is the first report about the pharmacokinetics (PK) of pranlukast in children. The aim of the present study was to assess the PK parameters of pranlukast in children and to compare them with those in adults. Methods: Six healthy adul
Externí odkaz:
https://doaj.org/article/be47850269bd48de8ce78c5445e79918
Publikováno v:
Pediatric Reports, Vol 1, Iss 1, Pp e9-e9 (2009)
The adverse effects or overdose of thioridazine including sudden death, fatal arrhythmia, or retinopathy, in addition to the neurological signs have been reported. A three-year-old boy with bronchitis was prescribed erythromycin by a local clinic, bu
Externí odkaz:
https://doaj.org/article/5a5c1c3200a5456fb5c28e0753a1de51
Autor:
Naomi Kondo, Toshiyuki Fukao, Takahide Teramoto, Zenichiro Kato, Norio Kawamoto, Hidenori Ohnishi, Hideo Kaneko, Taku Nakano, Hiroshi Ueno, Eiko Matsui, Minako Kawamoto
Publikováno v:
Allergy. 75:197-200
Autor:
Akira Hoshioka, Kazuko Sugai, Toshikazu Nagakura, Shigemi Yoshihara, Koichi Yamaguchi, Noriko Seko, Sankei Nishima, Akira Akasawa, Satoru Doi, Mitsuhiko Nambu, Takao Fujisawa, Kazuyuki Kurihara, Takahide Teramoto, Hiroshi Odajima, Toshio Katsunuma, Komei Ito, Norio Sato, Motohiro Ebisawa
Publikováno v:
Allergology International, Vol 66, Iss 1, Pp 106-115 (2017)
Background: Omalizumab is effective and well-tolerated in children with moderate to severe allergic asthma. However, the effects of long-term treatment with omalizumab in this population haven't been well investigated. The objective of this study is